Title: Predisposition to Addiction: Pharmacokinetics, Pharmacodynamics, and Brain Circuitry
Abstract: Back to table of contents Next article EditorialFull AccessPredisposition to Addiction: Pharmacokinetics, Pharmacodynamics, and Brain CircuitryPeter W. Kalivas, Ph.D.Peter W. Kalivas, Ph.D.Published Online:1 Jan 2003https://doi.org/10.1176/appi.ajp.160.1.1AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail There is now little doubt that the development of addiction to drugs of abuse is, in part, a function of predisposing factors in an individual's genome as well as factors associated with childhood and adolescent development. As much as drugs of abuse have profound pharmacological consequences on neuronal physiology, it is clear that while these drug actions are necessary, they are not sufficient for the development of addiction. When one compares the widespread recreational use of addictive drugs and the substantially fewer individuals meeting DMS-IV criteria for substance abuse disorder, it is apparent that drug pharmacology is only one factor in a multifactorial gene-environment-pharmacologic disorder. The search for the factors producing addiction and, more specifically, those factors that mediate the transition from recreational to compulsive (addicted) drug use has proceeded at all levels of investigation, from gene polymorphisms to sociological interventions. Exploring the factors causing addiction has primarily involved examining addicts for neurobiological and genetic differences from comparison subjects lacking a substance abuse disorder who are matched according to a variety of other biological, diagnostic, and sociological criteria. In this issue of the Journal, three research reports reflect different aspects of this research tactic. The article by Little et al. is indicative of perhaps the most traditional approach. As in many studies, postmortem tissue obtained from the caudate of cocaine addicts and matched comparison subjects was compared for protein content or function. This is an extension of many previous investigations that have hypothesized neuroadaptations in the proteins associated with the pharmacodynamic action of cocaine on dopamine transmission (1), pointing toward nigrostriatal dopamine depletion or perhaps a lesion in the caudate of addicts. Little et al. employ an arguably more definitive measure: the immunoreactive level of the central vesicular monoamine transporter protein (VMAT2) was used to verify that cocaine addicts have less of this critical enzyme for concentrating dopamine in synaptic vesicles. The authors recognize this as a pharmacological effect of heavy cocaine abuse and make no speculations as to whether this alteration is related to a predisposition for addiction or is even a marker of compulsive versus recreational cocaine use. However, as the authors note, it is likely that the down-regulation of VMAT2 is associated with high levels of recent drug use, since animal studies that do not involve the levels of drug administration typically observed in severe cocaine addicts do not show enduring alterations in the basal levels of any metric of dopamine transmission. The authors did, however, find hints of a predisposing or associated factor in that the capacity of cocaine to reduce VMAT2 was potentially more profound in addicts with associated mood disorder. Nonetheless, the research tactic of examining postmortem brain tissue for proteins directly associated with the pharmacological effects of the drug, while likely to yield drug-mediated differences, cannot assess the role of the neurobiological adaptation as a predisposing factor or even as an important factor in maintaining addiction. A primary reason for this lack of certainty can be found in the animal literature, where drug-induced changes in protein expression or function have been shown to depend on the time of sampling and to vary during drug administration and withdrawal. The general inability of postmortem studies in addicts to determine the length of abstinence or to sample at different points in the sequelae of drug taking, withdrawal, and craving severely limits the capacity to interpret the relationship between the pharmacodynamics of the drug and factors that predispose to or maintain addiction.A second paper in this issue of the Journal by Wall et al. is indicative of a widely used and potentially more profitable approach toward identifying predisposing factors in alcohol addiction. These authors studied a population of Native North American Indians to examine alcohol and aldehyde dehydrogenase polymorphisms as pharmacokinetic predisposing factors in alcoholism. Reminiscent of previous studies that have established that polymorphisms in one aldehyde dehydrogenase gene contribute strongly to reduced alcohol consumption and addiction in Asian populations (2), these authors demonstrate that polymorphisms in one of the alcohol dyhydrogenase genes is a predisposing factor in alcoholism in Native Americans. Not only does this information link a specific enzyme to alcohol dependence, but it confirms the utility of examining discrete populations with high levels of addiction as a mechanism for identifying important but relative uncommon polymorphisms. Although it is tempting to generalize findings between addictive substances, pharmacokinetic predispositions will not generally cross between drug classes where different catabolic or bioactivating enzymes are involved. In contrast, another research tactic has emerged over the last few years that can potentially identify common predisposing factors between different addictive substances. This tactic is based upon a deepening reservoir of neurophysiological knowledge regarding the functional brain circuits that mediate the physiological and pathological acquisition of environmental reinforcement, ranging from food and sex to gambling and addictive drugs (3). The most relevant information in this regard has emerged from increasingly sophisticated neuroimaging studies that point directly to the importance of interconnections between prefrontal and allocortical limbic brain regions and subcortical motor systems in addiction to all drugs of abuse examined. The third paper in this issue of the Journal combines this neurophysiological database with cognitive testing to probe whether poor performance in a decision-making task may be a shared trait between a population of adolescents known to be prone to developing addiction and adults meeting criteria for substance abuse disorder. Ernst et al. discovered that adolescents with externalizing behavioral disorders, including ADHD and conduct disorder, and adult addicts both performed poorly on aspects of repeated testing with the Gambling Task. On the basis of this finding, it is possible that a shared neurophysiological dysfunction may exist between drug addicts and adolescents with externalizing behavioral disorders, and poses the possibility that this may be a predisposing cognitive characteristic. While the authors identify many appropriate caveats to accepting this conclusion, the data point to important future studies that could combine neuroimaging with decision-making performance in the Gambling Task between these two populations. Such cognitive probes of neural circuitry combined with populations vulnerable to addictive disorders constitutes an experimental design that might reveal common circuitry dysfunctions that can begin to define a common pathological basis of predisposition to addiction. The potential for distinctions in brain circuitry to underlie predispositions in vulnerable populations stands in contrast to the pharmacokinetic or pharmacodynamic properties of individual drugs.Address reprint requests to Dr. Kalivas, Department of Physiology and Neuroscience, Medical University of South Carolina, 167 Ashley Ave., Suite 403, P.O. Box 250677, Charleston, SC 29425.REFERENCES1. Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nature Rev 2001; 2:119-128Crossref, Medline, Google Scholar2. Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M: Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995; 152:1219-1221Link, Google Scholar3. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA: Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000; 157:1789-1798Link, Google Scholar FiguresReferencesCited byDetailsCited byCommentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"11 October 2022 | Journal of Psychopharmacology, Vol. 37, No. 8Is there any link between celebrity suicide and further suicidal behaviour in India?8 October 2020 | International Journal of Social Psychiatry, Vol. 67, No. 5Borderline Personality Disorder: What Predicts Acute Psychiatric Readmissions?Journal of Personality Disorders, Vol. 35, No. 4Price preferences reveal asymmetric price effect—A preliminary study21 June 2021 | Journal of Sensory Studies, Vol. 36, No. 4Suicidality in Chronic Illness: An Overview of Cognitive–Affective and Interpersonal Factors31 October 2020 | Journal of Clinical Psychology in Medical Settings, Vol. 28, No. 1Suicidal Ideations and Attempts in Patients with Isolated Dystonia27 January 2021 | NeurologyThe clinical evaluation of the wish to hasten death is not upsetting for advanced cancer patients: A cross-sectional study28 January 2019 | Palliative Medicine, Vol. 33, No. 6CNS SpectrumsArchives of Suicide Research, Vol. 23, No. 4Journal of Occupational and Environmental Medicine, Vol. 61, No. 10Society and Economy, Vol. 41, No. 1Psychiatric Emergencies in Pregnancy and PostpartumClinical Obstetrics & Gynecology, Vol. 61, No. 3Enhanced "Train and Hope" for Scalable, Cost-Effective Professional Development in Youth Suicide PreventionCrisis, Vol. 39, No. 4The American Journal of Emergency Medicine, Vol. 36, No. 1Frontiers in Psychiatry, Vol. 9Community mental health care after self-harm: A retrospective cohort study12 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 51, No. 7Sustained Effectiveness of the Mental Health Environment of Care Checklist to Decrease Inpatient SuicideBradley V. Watts, M.D., M.P.H., Brian Shiner, M.D., M.P.H., Yinong Young-Xu, Sc.D., Peter D. Mills, Ph.D., M.S.15 November 2016 | Psychiatric Services, Vol. 68, No. 4Case–control study of risk factors for suicide attempts in Isfahan, Iran13 January 2017 | International Journal of Social Psychiatry, Vol. 63, No. 2Archives of Suicide Research, Vol. 21, No. 3Current Psychiatry Reports, Vol. 18, No. 9Counseling With Addicted Men4 November 2015Journal of Clinical Psychopharmacology, Vol. 35, No. 6International Journal of Psychiatry in Clinical Practice, Vol. 19, No. 1The World Journal of Biological Psychiatry, Vol. 16, No. 4Systematic Suicide Risk Assessment for Patients With Schizophrenia: A National Population-Based StudyCharlotte Gjørup Pedersen, Ph.D., M.H.Sc., Signe Olrik Wallenstein Jensen, M.Sc., Jaimie Gradus, Ph.D., M.H.Sc., Søren Paaske Johnsen, Ph.D., M.D., and Jan Mainz, Ph.D., M.D.1 February 2014 | Psychiatric Services, Vol. 65, No. 2Computer Speech & Language, Vol. 28, No. 2Medical Hypotheses, Vol. 82, No. 3On the road to addiction: The facilitative and preventive roles of marketing cuesJournal of Business Research, Vol. 66, No. 8Social Psychiatry and Psychiatric Epidemiology, Vol. 48, No. 3Psychotherapeut, Vol. 58, No. 3British Journal of Guidance & Counselling, Vol. 41, No. 4Journal of Palliative Medicine, Vol. 16, No. 8Journal of Palliative Medicine, Vol. 16, No. 11The Linares Addictive Potential Model5 June 2012 | Journal of Pharmacy and Nutrition Sciences, Vol. 2, No. 2Revista Española de Medicina Legal, Vol. 38, No. 4Pain Medicine, Vol. 13, No. 4Expert Review of Neurotherapeutics, Vol. 12, No. 3Ethical Human Psychology and Psychiatry, Vol. 14, No. 2Suicide Attempts: Prevention of Repetition1 October 2011 | The Canadian Journal of Psychiatry, Vol. 56, No. 10The Role of Suicide Risk in the Decision for Psychiatric Hospitalization After a Suicide AttemptCrisis, Vol. 32, No. 2Alcohol, Vol. 45, No. 7Depression and a Stepped Care Model7 October 2010Separation as an Important Risk Factor for Suicide: A Systematic Review26 March 2010 | Journal of Family Issues, Vol. 31, No. 12Substance Abuse Issues in Oral and Maxillofacial PracticeOral and Maxillofacial Surgery Clinics of North America, Vol. 22, No. 4Reassessment of Suicide Attempters at Home, Shortly After Discharge from HospitalCrisis, Vol. 31, No. 6Clinical Characteristics of Depressed Patients With a History of Suicide AttemptsJournal of Nervous & Mental Disease, Vol. 198, No. 10Mental Illness Requires a Multidisciplinary PlanScience, Vol. 328, No. 5983Journal of Nursing Regulation, Vol. 1, No. 2Hallucinations, Pseudohallucinations, and Severity of Suicidal Ideation Among Emergency Psychiatry PatientsCrisis, Vol. 31, No. 1Canadian Journal of Community Mental Health, Vol. 29, No. 1Suicide and Life-Threatening Behavior, Vol. 39, No. 6Expert Review of Neurotherapeutics, Vol. 9, No. 1The Opportunity for Psychiatry in Palliative Care1 November 2008 | The Canadian Journal of Psychiatry, Vol. 53, No. 11The Development and Utilisation of a Suicide Risk Assessment Interview Schedule1 June 2008 | South African Journal of Psychology, Vol. 38, No. 2Adequacy of, Attitudes Toward, and Adherence to Treatments by Suicidal and Nonsuicidal Depressed PatientsJournal of Nervous & Mental Disease, Vol. 196, No. 3Disease-a-Month, Vol. 54, No. 10CJEM, Vol. 10, No. 02CJEM, Vol. 10, No. 02Journal of Palliative Medicine, Vol. 11, No. 2Brief Treatment and Crisis Intervention, Vol. 8, No. 3Dissociative Disorders and Suicidality in Psychiatric OutpatientsJournal of Nervous & Mental Disease, Vol. 196, No. 1Suicide Mortality Among Individuals Receiving Treatment for Depression in the Veterans Affairs Health System: Associations with Patient and Treatment Setting CharacteristicsAmerican Journal of Public Health, Vol. 97, No. 12Depression and Anxiety, Vol. 24, No. 6International Journal of Eating Disorders, Vol. 40, No. 7CyberPsychology & Behavior, Vol. 10, No. 4DuloxetineJournal of Clinical Psychopharmacology, Vol. 26, No. 6What Happened to Lithium? Antidepressant Augmentation in Clinical SettingsMarcia Valenstein, M.D., M.S.John F. McCarthy, Ph.D.Karen L. Austin, M.P.H.John F. Greden, M.D.Elizabeth A. Young, M.D.Frederic C. Blow, Ph.D.1 July 2006 | American Journal of Psychiatry, Vol. 163, No. 7Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth20 September 2005 | Journal of Psychopharmacology, Vol. 20, No. 4Suicide after Surgical Treatment in Patients with Epilepsy: A Meta-Analytic Investigation31 August 2016 | Psychological Reports, Vol. 98, No. 2Journal of Clinical Psychology, Vol. 62, No. 2Pharmacoepidemiology and Drug Safety, Vol. 15, No. 12Journal of Abnormal Psychology, Vol. 115, No. 3Epidemiology and risk factors for suicide in the elderly: 10-year updateAging Health, Vol. 1, No. 1American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Vol. 133C, No. 1Pharmacology Biochemistry and Behavior, Vol. 82, No. 1Acta Psychiatrica Scandinavica, Vol. 112, No. 2International Journal of Forensic Mental Health, Vol. 3, No. 2Acta Psychiatrica Scandinavica, Vol. 109, No. 4Alcohol and Alcoholism, Vol. 38, No. 5 Volume 160Issue 1 January 2003Pages 1-2 Metrics PDF download History Published online 1 January 2003 Published in print 1 January 2003
Publication Year: 2003
Publication Date: 2003-01-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 297
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot